+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Clinical Chemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020

  • ID: 5205445
  • Report
  • November 2020
  • Region: Global
  • 209 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abreos Biosciences Inc
  • Baebies Inc
  • Columbia University
  • Group K Diagnostics
  • Novartis AG
  • PortaScience Inc
  • MORE
Summary

The publisher's Medical Devices sector report, “Clinical Chemistry Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Clinical Chemistry Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Clinical chemistry rapid tests provide the test results immediately. These tests are used in low resource settings with the help of test strips, tablets and solutions.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Clinical Chemistry Rapid Tests & POC under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Clinical Chemistry Rapid Tests & POC and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Clinical Chemistry Rapid Tests & POC under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abreos Biosciences Inc
  • Baebies Inc
  • Columbia University
  • Group K Diagnostics
  • Novartis AG
  • PortaScience Inc
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Clinical Chemistry Rapid Tests & POC Overview

3 Products under Development
3.1 Clinical Chemistry Rapid Tests & POC - Pipeline Products by Stage of Development
3.2 Clinical Chemistry Rapid Tests & POC - Pipeline Products by Territory
3.3 Clinical Chemistry Rapid Tests & POC - Pipeline Products by Regulatory Path
3.4 Clinical Chemistry Rapid Tests & POC - Pipeline Products by Estimated Approval Date
3.5 Clinical Chemistry Rapid Tests & POC - Ongoing Clinical Trials

4 Clinical Chemistry Rapid Tests & POC - Pipeline Products under Development by Companies
4.1 Clinical Chemistry Rapid Tests & POC Companies - Pipeline Products by Stage of Development
4.2 Clinical Chemistry Rapid Tests & POC - Pipeline Products by Stage of Development

5 Clinical Chemistry Rapid Tests & POC Companies and Product Overview

6 Clinical Chemistry Rapid Tests & POC- Recent Developments

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact

List of Tables
Table 1: Clinical Chemistry Rapid Tests & POC - Pipeline Products by Stage of Development
Table 2: Clinical Chemistry Rapid Tests & POC - Pipeline Products by Territory
Table 3: Clinical Chemistry Rapid Tests & POC - Pipeline Products by Regulatory Path
Table 4: Clinical Chemistry Rapid Tests & POC - Pipeline Products by Estimated Approval Date
Table 5: Clinical Chemistry Rapid Tests & POC - Ongoing Clinical Trials
Table 6: Clinical Chemistry Rapid Tests & POC Companies - Pipeline Products by Stage of Development
Table 7: Clinical Chemistry Rapid Tests & POC - Pipeline Products by Stage of Development
Table 8: Abreos Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Veritope ELISA Based Immunoassay - Natalizumab - Product Status
Table 10: Veritope ELISA Based Immunoassay - Natalizumab - Product Description
Table 11: Veritope Lateral Flow Immunoassay - Adalimumab - Product Status
Table 12: Veritope Lateral Flow Immunoassay - Adalimumab - Product Description
Table 13: Veritope Lateral Flow Immunoassay - Cetuximab - Product Status
Table 14: Veritope Lateral Flow Immunoassay - Cetuximab - Product Description
Table 15: Veritope Lateral Flow Immunoassay - Daratumumab - Product Status
Table 16: Veritope Lateral Flow Immunoassay - Daratumumab - Product Description
Table 17: Veritope Lateral Flow Immunoassay - Eculizumab - Product Status
Table 18: Veritope Lateral Flow Immunoassay - Eculizumab - Product Description
Table 19: Veritope Lateral Flow Immunoassay - Infliximab - Product Status
Table 20: Veritope Lateral Flow Immunoassay - Infliximab - Product Description
Table 21: Veritope Lateral Flow Immunoassay - Nivolumab - Product Status
Table 22: Veritope Lateral Flow Immunoassay - Nivolumab - Product Description
Table 23: Veritope Lateral Flow Immunoassay - Pertuzumab - Product Status
Table 24: Veritope Lateral Flow Immunoassay - Pertuzumab - Product Description
Table 25: Veritope Lateral Flow Immunoassay - Ramucirumab - Product Status
Table 26: Veritope Lateral Flow Immunoassay - Ramucirumab - Product Description
Table 27: Veritope Lateral Flow Immunoassay - Tocilizumab - Product Status
Table 28: Veritope Lateral Flow Immunoassay - Tocilizumab - Product Description
Table 29: Acetaminophen Toxicity Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 30: AcetaSTAT(r) - Product Status
Table 31: AcetaSTAT(r) - Product Description
Table 32: Affinergy LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Point-Of-Care Lateral Flow Assay - Vancomycin - Product Status
Table 34: Point-Of-Care Lateral Flow Assay - Vancomycin - Product Description
Table 35: Am Biotechnologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Thioaptamer Diagnostic System - sALP Biomarker - Product Status
Table 37: Thioaptamer Diagnostic System - sALP Biomarker - Product Description
Table 38: Thioaptamers Diagnostic System - Gpx Biomarker - Product Status
Table 39: Thioaptamers Diagnostic System - Gpx Biomarker - Product Description
Table 40: AnaZyme LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Blood-Based Assay - Absence Of Specific Compounds - Product Status
Table 42: Blood-Based Assay - Absence Of Specific Compounds - Product Description
Table 43: Blood-Based Assay - Specific Enzymes - Product Status
Table 44: Blood-Based Assay - Specific Enzymes - Product Description
Table 45: Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Point-Of-Care Diagnostic Test - TBI - Product Status
Table 47: Point-Of-Care Diagnostic Test - TBI - Product Description

List of Figures
Figure 1: Clinical Chemistry Rapid Tests & POC - Pipeline Products by Stage of Development
Figure 2: Clinical Chemistry Rapid Tests & POC - Pipeline Products by Territory
Figure 3: Clinical Chemistry Rapid Tests & POC - Pipeline Products by Regulatory Path
Figure 4: Clinical Chemistry Rapid Tests & POC - Pipeline Products by Estimated Approval Date
Figure 5: Clinical Chemistry Rapid Tests & POC - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • Abreos Biosciences Inc
  • Acetaminophen Toxicity Diagnostics, LLC
  • Affinergy LLC
  • Am Biotechnologies, LLC
  • AnaZyme LLC
  • Angle Biosciences Inc
  • Atonomics A/S
  • Augurix SA
  • Baebies Inc
  • Base Pair Biotechnologies Inc
  • Biocross SL
  • Bioftalmik Applied Research
  • Biotech Resources Aust Pty Ltd
  • Boditech Med Inc
  • Burnet Institute
  • Carclo Diagnostic Solutions Ltd
  • CardioGenics Inc
  • Cellex Inc
  • Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine
  • Claremont BioSolutions
  • Columbia University
  • CTK Biotech Inc
  • DiaSys Diagnostic Systems GmbH
  • Edan Instruments Inc
  • Enesi Pharma Ltd
  • Enigma Diagnostics Ltd (Inactive)
  • Erytech Pharma SA
  • FK-Biotecnologia SA
  • Foundation for Innovative New Diagnostics
  • Gendiag
  • Group K Diagnostics
  • Instrumentation Laboratory Co
  • Integrated Diagnostics Inc (Inactive)
  • IntraMed Diagnostics, LLC
  • IPI Singapore
  • Iron Horse Diagnostics, Inc.
  • Kenyatta University
  • Massachusetts Institute of Technology
  • Medical University of South Carolina
  • Monash University
  • Montana State University
  • NanoSpeed Diagnostics Inc
  • Novartis AG
  • Ohmx Corp
  • OPKO Health Inc
  • Oxford Immunotec Ltd
  • P2D Inc
  • Pennsylvania State University
  • Philips Healthcare
  • Pop Test LLC
  • PortaScience Inc
  • ProciseDx LLC
  • Quidel Corp
  • SaltCheck Inc (Inactive)
  • Seattle Children's Hospital
  • SenGenix Inc
  • SuperNova Diagnostics, Inc.
  • Systagenix Wound Management Ltd
  • The University of New South Wales press Limited
  • Thermo Fisher Scientific Inc
  • Trivitron Healthcare Pvt Ltd
  • True Diagnostics Inc
  • Universal Biosensors Inc
  • University of Edinburgh
  • University of South Australia
  • UrSure Inc
Note: Product cover images may vary from those shown
Adroll
adroll